Comparative pharmacodynamic (PD) study of 6 epoetin alfa dosing regimens in anemic critically ill patients.

被引：0
|
作者：
Kelly, K.
Marino, Kimberly
Guntupalli, K.
Arroliga, C.
机构：
[1] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Cleveland Clin, Cleveland, OH USA
来源：
CRITICAL CARE MEDICINE | 2006年 / 34卷 / 12期
关键词：
D O I：
10.1097/00003246-200612002-00511
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
530
引用
收藏
页码：A147 / A147
页数：1
相关论文
共 50 条
  • [21] INDIVIDUALIZING VANCOMYCIN DOSING REGIMENS - AN EVALUATION OF 2 PHARMACOKINETIC DOSING PROGRAMS IN CRITICALLY ILL PATIENTS
    DEGATTA, MDF
    FRUNS, I
    DOMINGUEZGIL, A
    PHARMACOTHERAPY, 1994, 14 (02): : 196 - 201
  • [22] Alternate dosing strategies of epoetin alfa in pre-dialysis chronic kidney disease patients.
    Sarac, E
    Smavatkul, C
    Boolchand, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 794A - 794A
  • [23] Dosing and transfusion patterns of erythropoietic stimulating therapies in critically ill patients.
    Vekeman, Francis
    Lefebvre, Patrick
    Mody, Samir H.
    Raut, Monika
    McKenzie, R. S.
    Watson, Sue
    Duh, Mei S.
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A128 - A128
  • [24] A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease
    Spinowitz, Bruce
    Germain, Michael
    Benz, Robert
    Wolfson, Marsha
    McGowan, Tracy
    Tang, K. Linda
    Kamin, Marc
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (04): : 1015 - 1021
  • [25] Using PK/PD to Optimize Antibiotic Dosing for Critically Ill Patients
    Roberts, Jason A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2070 - 2079
  • [26] A comparative study of the complications of surgical tracheostomy in morbidly obese critically ill patients.
    El Solh, Ali A.
    Jaafar, Wafaa
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A95 - A95
  • [27] Pharmacokinetic-Pharmacodynamic- Model-Guided Doripenem Dosing in Critically Ill Patients
    Samtani, Mahesh N.
    Flamm, Robert
    Kaniga, Kone
    Nandy, Partha
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2360 - 2364
  • [28] Pharmacokinetic (PK) pharmacodynamic (PD) determination of propofol (P) dosing in critically ill, mechanically ventilated (MV) pediatric patients (Pts)
    Reed, M
    Yamashita, T
    Myers, C
    Blumer, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII63 - PII63
  • [29] Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy
    Chaijamorn, Weerachai
    Puchsaka, Punyawee
    Pattharachayakul, Sutthiporn
    Charoensareerat, Taniya
    Srisawat, Nattachai
    Boonpeng, Apinya
    Pummangura, Chalermsri
    JOURNAL OF CRITICAL CARE, 2019, 52 : 233 - 236
  • [30] Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?
    Ollivier, Julien
    Carrie, Cedric
    d'Houdain, Nicolas
    Djabarouti, Sarah
    Petit, Laurent
    Xuereb, Fabien
    Legeron, Rachel
    Biais, Matthieu
    Breilh, Dominique
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
12345